End-of-treatment measurements

As antihypertensive drugs are intended to lower blood pressure, their evaluation in clinical trials requires at least two measurements. One of these is an initial measurement, typically called a baseline measurement, and the other is a measurement some time later, such as at the end of the treatment phase (the end-of-treatment measurement). These two measurements allow us to calculate a change score that represents the change in blood pressure from the start to the end of the treatment phase. Change scores can be calculated in several ways. One of these, and the method that is used in all of the examples in this book, is simply to calculate the arithmetic difference between each individual s baseline measurement and his or her end-of-treatment measurement. 

Measure these outcomes at the end of treatment to determine the end-of-treatment response and at 24 weeks after treatment has been discontinued to determine SVR. 

Psychotherapy looks even better when its long-term effectiveness is assessed.17 Formerly depressed patients are far more likely to relapse and become depressed again after treatment with antidepressants than they are after psychotherapy. As a result, psychotherapy is significantly more effective than medication when measured some time after treatment has ended, and the more time that has passed since the end of treatment, the larger the difference between drugs and psychotherapy. This long-term advantage of psychotherapy over medication is independent of the severity of the depression. Psychotherapy outperforms antidepressants for severely depressed patients as much as it does for those who are mildly or moderately depressed.18... 

This was demonstrated by GC/MS measurements using a headspace sampler. Equivalent tissue segments of freshly enucleated and vitrectomised eyes of pig were prepared and rinsed for 30 min with PFD after a simulated VR surgery using different types of partially fluorinated liquids as endotamponade media. PFO was used as a reference. At the end of treatment, they were rinsed with PFD to clean the surfaces. 

The initial reports from open studies (Artigas et al. 1994 Blier and Bergeron 1995) suggest that the combination is associated with improved efficacy with probable faster onset of action. This rapid response was reported with augmentation of fluoxetine and paroxetine, and more recently with nefazodone (Bakish et al. 1997), but interestingly not with sertraline or low doses of fluvoxamine. These results needed to be confirmed in placebo-controlled studies, and the reports from large studies do indeed find an acceleration of response measured as time to response and possible superiority of action with some antidepressants at the end of treatment (Perez et al. 1997 Tome de la Granja et al. 1997). 

E. Therapeutic response Efficacy of Infergen therapy was determined by measurement of serum alanine aminotransferase (ALT) concentrations at the end of therapy (24 weeks) and following 24 weeks of observation after the end of treatment of adults with chronic HCV infection. Serum HCV RNA was also assessed using a quantitative reverse transcriptase polymerase chain reaction (RT-PCR). At the end of 24 weeks of treatment, ALT normalization was observed in 39% of patients on Infergen and in 35% of patients on interferon alfa-2b Intron A). Only 17% of patients in each group... 

When norfloxacin was given to broilers and laying hens, the highest residue concentrations were measured in tissues on day 5 of drug administration and on day 0 after the end of treatment (185). Concentrations were highest in liver at 4867 ppb and 4496 ppb on day 5 and day 0, respectively. On day 1 after tlie end of treatment, the level of norfloxacin decreased, with highest concentrations measured in the liver (76 ppb) and lowest in heart (17.5 ppb). By day 3, concentrations had fallen to 13 ppb in liver and 21.3 ppb in muscle. No residues were measured in tissues on days 6, 7, and 9 after the end of treatment except in muscle where 7.5 ppb was detected on day 9. The concentrations of norfloxacin measured in eggs increased steadily over the treatment period. Concentrations at days 3... 

In a randomized controlled trial of high-dose interferon alfa-2b pins oral ribavirin for 6 or 12 months in 50 patients with chronic hepatitis C, the seqnential effects of treatment on hemoglobin, leukocytes, and platelets were recorded (14). There was a fall in hemoglobin, and the lowest concentrations were recorded after 6 months of treatment in both groups. All hematological measurements retnmed to normal after the end of treatment. 

Redox experiments and ESR determination of Cu2+ were performed with a circulation all-glass apparatus equipped with a magnetically driven pump. The sample (0.2 to 1.0 g) was placed in a silica reactor equipped with a side ESR tube. All the samples before the redox cycles were treated in O2 at 773 K. The redox cycles consisted of (i) heating in He flow at 823 K for 2h, followed by evacuation at 773 K and heating in O2 at 773 K (ii) evacuation at RT followed by reduction with CO at 773 K (iii) evacuation at 773 K followed by a second treatment with O2 at 773 K. During the treatments (i) to (iii), the pressure of O2 or CO was monitored with a pressure transducer (MKS Baratron, sensitivity 1 Pa) until a nearly constant pressure was reached. All these measurements allowed the variation of the average oxidation number of copper to be followed. The acquisition or loss of electrons are expressed as e/Cu (number of electrons/total number of Cu atoms). At the end of treatments (i) to (iii), ESR spectra of Cu2+ species were recorded at RT. ESR measurements were carried out on a Varian E-9 spectrometer equipped with an on line computer. Absolute concentrations of... 

The use of the MCQ in a treatment setting may be more flexible than in a research setting. A patient s level of craving may be assessed at initial intake or at baseline before entering treatment. Craving can then be measured periodically during and at the end of treatment to determine treatment outcome. Presumably, craving levels will decrease as a person reduces cannabis use or achieves abstinence. 

Figure 12.11. Dynamic surface tensions of blood serum samples as measured by the drop shape technique (PATl, SIN-TECH-Berlin, Germany, (0, )) and maximum bubble pressure method (MPT2, LAUDA, Germany, ( , )), samples taken from a 43 years old woman suffering from cervical carcinoma , , before radiotherapy o, at the end of treatment...

Years of regulation have greatly lowered releases of water pollutants from industrial operations due largely to sophisticated water treatment operations that are applied to water before it is released from a plant. Desirable as these end-of-pipe measures are, the practice of industrial ecology goes beyond such pollution control, minimizing the use of water and preventing its pollution in the first place. One way to ensure that water pollutants are not released from an industrial operation is to completely recycle the water in the system—no water out, no water pollutants. 

Discharges of water pollutants should be entirely eliminated wherever possible. For many decades, efficient and effective water treatment systems have been employed that minimize water pollution. However, these are end of pipe measures, and it is much more desirable to design industrial systems sueh that potential water pollutants are not even generated. 

At the end of treatment, HL-60 cells were stained with 40 nM 3,3 -dihexyloxacarbocyanine (DiOC6 (3), Molecular Probes, Eugene, OR) for 15 min at 37 C. Mitochondrial transmembrane potential was measured by flow cytometry. At least 10,000 cells were collected in each sample. Generation of ROS was monitored with 20 pM 2, 7 -dichlorofluorescein diacetate (DCFH-DA) (Molecular Probes, Eugene, OR) staining for 1 h at 37 C and assayed by flow cytometry. 

The induction of necrosis is both time and temperature dependent i.e. cell death requires a longer period of modestly elevated temperature but occurs within 1 min at temperatures over 80°C. Spot temperature measurements can be gathered from thermo-sensors at the tip of the electrodes either during treatment, at the end of treatment or after a cool-down period. Recent innovations include the incorporation of a thermo-sensor that is deployed perpendicular to the electrode shaft and can be repetitively deployed in different areas as required. US have been used to measure temperature but most clinical research has centred on MR monitoring... 

At the top end of the program monitoring scale is the use of online fluorescence tracing systems, whereby tracer dye polymers form part of the water treatment program and their concentration can be measured online at various locations throughout the boiler plant system. Much less expensive, handheld fluorometers are now available to conduct the same type of analysis at the laboratory bench or on the boiler house firing-floor. These tracer dye polymers can be used to determine ... 

It also appears that most commonly available technical books and other sources of literature tend to concentrate on the higher pressure glamour end of the boiler plant range, and there is little that is sufficiently practical or comprehensive concerning the lower pressure market. And, of course, it is this lower pressure market (when measured by physical number) that globally constitutes the vast majority of boilers and where the user skills and experience in applied water treatment are most often limited. 

Hypotension may be related to alterations in levocarnitine levels during dialysis. Patients who have low levels of levocarnitine may benefit from supplementation. Levocarnitine is administered as doses of 20 mg/kg intravenously at the end of each dialysis session. However, levocarnitine should not be used as a first-line agent for the treatment of hypotension because of the significant cost associated with the treatment. Patients receiving levocarnitine should be evaluated every 3 months for response to therapy.47 Other preventive measures that have not been well studied include caffeine, sertraline, or fludrocortisone. 

---